{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:41:55Z","timestamp":1790379715098,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"am","delay-in-days":310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jsat.2022.108891","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T13:17:33Z","timestamp":1664543853000},"page":"108891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network"],"prefix":"10.1016","volume":"143","author":[{"given":"Barbara","family":"L\u00e9pine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Debin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Dassieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Palmaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Pont\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Swital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Blanchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dupouy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsat.2022.108891_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3122\/jabfm.2020.01.190233","article-title":"Characteristics of office-based buprenorphine prescribers for medicare patients","volume":"33","author":"Abraham","year":"2020","journal-title":"Journal of the American Board of Family Medicine"},{"key":"10.1016\/j.jsat.2022.108891_bb0010","series-title":"Etat des lieux de la consommation des antalgiques opio\u00efdes et leurs usages probl\u00e9matiques","year":"2019"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2022.108891_bb0015","first-page":"S17","article-title":"French field experience with buprenorphine","volume":"13","author":"Auriacombe","year":"2004","journal-title":"The American Journal on Addictions"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2022.108891_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2022.108891_bb0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/IJGM.S61014","article-title":"The current status of opioid maintenance treatment in France: A survey of physicians, patients, and out-of-treatment opioid users","volume":"7","author":"Benyamina","year":"2014","journal-title":"International Journal of General Medicine"},{"key":"10.1016\/j.jsat.2022.108891_bb0030","series-title":"Tableau de bord \u2018Traitements de substitution aux opioides\u2019: Mise \u00e0 jour 2020","author":"Brisacier","year":"2020"},{"issue":"1","key":"10.1016\/j.jsat.2022.108891_bb0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ejp.1291","article-title":"Prescription opioid analgesic use in France: Trends and impact on morbidity-mortality","volume":"23","author":"Chenaf","year":"2019","journal-title":"European Journal of Pain"},{"key":"10.1016\/j.jsat.2022.108891_bb0040","first-page":"3019","article-title":"Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians","volume":"15","author":"DeFlavio","year":"2015","journal-title":"Rural and Remote Health"},{"issue":"18","key":"10.1016\/j.jsat.2022.108891_bb0045","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1080\/14656566.2017.1409722","article-title":"Recommendations for buprenorphine and methadone therapy in opioid use disorder: A european consensus","volume":"18","author":"Dematteis","year":"2017","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.jsat.2022.108891_bb0050","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000506630","article-title":"Primary care of opioid use disorder: The end of \u2018the French Model\u2019?","volume":"26","author":"Dupouy","year":"2020","journal-title":"European Addiction Research"},{"issue":"4","key":"10.1016\/j.jsat.2022.108891_bb0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1370\/afm.2098","article-title":"Mortality associated with time in and out of buprenorphine treatment in french office-based general practice: A 7-year cohort study","volume":"15","author":"Dupouy","year":"2017","journal-title":"Annals of Family Medicine"},{"key":"10.1016\/j.jsat.2022.108891_bb0060","series-title":"European drug report 2019: Trends and developments","year":"2019"},{"issue":"5","key":"10.1016\/j.jsat.2022.108891_bb0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11920-007-0046-2","article-title":"Why buprenorphine is so successful in treating opiate addiction in France","volume":"9","author":"Fatseas","year":"2007","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.jsat.2022.108891_bb0070","series-title":"Practice guidelines for the administration of buprenorphine for treating opioid use disorder","year":"2021"},{"key":"10.1016\/j.jsat.2022.108891_bb0075","series-title":"Barom\u00e8tre sant\u00e9 m\u00e9decins g\u00e9n\u00e9ralistes 2009","author":"Gautier","year":"2011"},{"issue":"10","key":"10.1016\/j.jsat.2022.108891_bb0080","article-title":"French experience with buprenorphine: Do physicians follow the guidelines?","volume":"10","author":"Landreat","year":"2015","journal-title":"Plos One"},{"issue":"7529","key":"10.1016\/j.jsat.2022.108891_bb0085","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/bmj.331.7529.1352","article-title":"Is methadone too dangerous for opiate addiction?","volume":"331","author":"Luty","year":"2005","journal-title":"British Medical Journal"},{"issue":"9","key":"10.1016\/j.jsat.2022.108891_bb0090","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/M18-1652","article-title":"The next stage of buprenorphine care for opioid use disorder","volume":"169","author":"Martin","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2022.108891_bb0095","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.","volume":"2","author":"Mattick","year":"2014","journal-title":"TheCochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2022.108891_bb0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugpo.2019.10.005","article-title":"Ambiguous identities of drugs and people: A scoping review of opioid-related stigma","volume":"74","author":"McCradden","year":"2019","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.jsat.2022.108891_bb0105","article-title":"Enqu\u00eate sur la prise en charge des patients d\u00e9pressifs en soins primaires: Les m\u00e9decins g\u00e9n\u00e9ralistes ont des difficult\u00e9s et des solutions","volume":"36","author":"Mercier","year":"2010","journal-title":"Encephale-Revue De Psychiatrie Clinique Biologique Et Therapeutique"},{"issue":"3","key":"10.1016\/j.jsat.2022.108891_bb0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jsat.2008.06.006","article-title":"Factors affecting willingness to provide buprenorphine treatment","volume":"36","author":"Netherland","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108891_bb0115","series-title":"\u00c9volution de la consommation de bupr\u00e9nophine haut dosage et de m\u00e9thadone depuis 1995","year":"2018"},{"key":"10.1016\/j.jsat.2022.108891_bb0120","series-title":"Bilan d\u2019activit\u00e9 2020","year":"2021"},{"issue":"9","key":"10.1016\/j.jsat.2022.108891_bb0125","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.jsat.2022.108891_bb0130","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995\u20132009","volume":"103","author":"Schwartz","year":"2013","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2022.108891_bb0135","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2022.108891_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12963-014-0019-8","article-title":"Improving disease incidence estimates in primary care surveillance systems","volume":"12","author":"Souty","year":"2014","journal-title":"Population Health Metrics"},{"issue":"1","key":"10.1016\/j.jsat.2022.108891_bb0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12875-016-0413-3","article-title":"Study protocol of the ESUB-MG cluster randomized trial: A pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients","volume":"17","year":"2016","journal-title":"BMC Family Practice"},{"issue":"2 Suppl","key":"10.1016\/j.jsat.2022.108891_bb0150","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00056-5","article-title":"The clinical pharmacology of buprenorphine: Extrapolating from the laboratory to the clinic","volume":"70","author":"Walsh","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2022.108891_bb0155","author":"WHO Expert Committee on Drug Dependence"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222001738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222001738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:57:50Z","timestamp":1760039870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547222001738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":31,"alternative-id":["S0740547222001738"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108891","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108891"}}